What are United Therapeutics's profit margins?

United Therapeutics (UTHR) runs a 86.6% gross margin and a 45.3% operating margin, with a 40.6% net margin.

Where do United Therapeutics's ratios come from?

Every ratio is computed from United Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

United Therapeutics UTHR Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	352.1%-3.9pp	354.5%-1.4pp	355.8%+0.2pp	356.2%+0.6pp	356%-0.6pp
Operating margin	187%-2.5pp	188.6%-4.3pp	189.5%-6.4pp	188.2%-11.2pp	189.4%-13.2pp
Net margin	163.6%+0.4pp	163.4%-1.4pp	163%-2.6pp	162.6%-3.4pp	163.1%-3.3pp
EBITDA margin	197.7%-1.6pp	199.1%-3.3pp	199.8%-5.3pp	198.3%-10.3pp	199.3%-12.8pp
Free cash flow margin	135.4%-5.9pp	141.1%+7.2pp	145.9%+17.5pp	142.6%+12.2pp	141.4%+12.6pp
Returns
Return on equity	79.3%+2.1pp	79%+1.6pp	78.5%+2.1pp	77.3%+2.2pp	77.2%+3.4pp
Return on assets	69.9%+4.8pp	69.1%+4.6pp	68%+5.1pp	66.1%+4.9pp	65.1%+5.5pp
Efficiency
Asset turnover	1.7×+0.1×	1.7×+0.1×	1.7×+0.1×	1.6×+0.2×	1.6×+0.2×
Inventory turnover	9.2×-0.3×	9×-0.7×	9×-0.7×	9.2×-0.6×	9.5×-0.2×
Liquidity
Current ratio	25.1×+5.4×	25.7×+7.8×	24.4×+7.2×	22.5×+5.4×	19.6×-1.9×
Quick ratio	23.8×+4.9×	24.5×+7.3×	23.3×+6.8×	21.6×+5.0×	18.9×-2.0×
Cash ratio	10.4×+2.0×	10.9×+3.7×	10.4×+4.0×	9.7×+3.7×	8.3×+1.0×
Leverage
Interest coverage	271.6×+152×	223.4×+122×	179×+89.4×	143.1×+59.5×	119.7×+37.1×
Per Share
Book value per share	$561.02+8.1%	$576.06+18.5%	$560.78+18.4%	$547.51+18.3%	$518.92+14.8%
Valuation
Market capitalization	$79.01B+30.6%	$66.86B+16.4%	$61.63B+18.5%	$58.59B+25.5%	$60.48B+43.7%
Price / earnings	61.3×+8.4×	52.6×+0.8×	50.1×+1.0×	49.5×+2.9×	52.9×+8.5×
Price / sales	25.1×+3.5×	21.5×+0.2×	20.4×+0.2×	20.1×+0.8×	21.6×+3.1×
Price / book	12.1×+2.3×	9.7×0.0×	9.2×+0.2×	8.9×+0.7×	9.7×+2.2×
Free cash flow yield	23%-3.5pp	27.2%+1.9pp	29.1%+3.4pp	28.8%+1.6pp	26.5%-1.4pp
Earnings yield	27.5%-2.9pp	31.3%-0.1pp	32.5%-0.8pp	32.8%-2.1pp	30.5%-5.7pp
PEG ratio	6.2×+3.6×	3.8×+1.7×	3×+1.3×	2.6×+1.1×	2.6×+1.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about United Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are United Therapeutics's profit margins?: United Therapeutics (UTHR) runs a 86.6% gross margin and a 45.3% operating margin, with a 40.6% net margin.
Where do United Therapeutics's ratios come from?: Every ratio is computed from United Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.